AzTrials
AzTrials

Cardiovascular DiseasePhase 1FIRSTNCT00874341

Effect of Fruit and Vegetables on Insulin Resistance

A Phase 1 study testing Fruit and vegetable intervention in people with Cardiovascular Disease, run by Queen's University, Belfast at 2 sites in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Current evidence indicates that fruit and vegetable intake and dietary patterns rich in fruit and vegetables may be associated with reduced insulin resistance and may reduce the risk of the metabolic syndrome. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Cardiovascular Disease
What is being tested?
Fruit and vegetable intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
105 participants
Where
2 sitesUnited Kingdom
Study dates
Jan 2009to Jul 2011
Phase
Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • BMI between 27-35
  • CVD risk >20% over 10 years (using the Joint British Society risk assessment tables)
  • Low consumers of fruit and vegetables (<2 portions per day)

Who cannot join

  • Diabetes
  • Existing CVD
  • Food intolerance/sensitivity preventing adherence to a high fruit and vegetable diet
  • Subjects taking antioxidant supplements
  • Surgery within the last 3 months
  • Pregnancy/lactation
  • Aspirin
  • Subjects following a weight loss diet

Trial locations and contacts

2 sites in 1 country.

United Kingdom2 sites
  • Queen's University Belfast

    Belfast, Northern Ireland, BT12 6BJ

  • Royal Victoria Hospital

    Belfast, BT12 6BJ

Other trials in United Kingdom

About this study

Official title: Dose-Response Effect of Fruit and Vegetables on Insulin Resistance in Healthy People Who Are Overweight and at High Risk of Cardiovascular Disease

Current evidence indicates that fruit and vegetable intake and dietary patterns rich in fruit and vegetables may be associated with reduced insulin resistance and may reduce the risk of the metabolic syndrome. If proven, this relationship may partly explain the inverse association between fruit and vegetable intake and cardiovascular disease risk. There are currently no published dietary interventions that have examined in detail the relationship between fruit and vegetable intake and insulin resistance. There is, however, some preliminary evidence from whole diet interventions that a diet rich in fruit and vegetables may have a beneficial effect on insulin resistance. Evidence to date indicates that an investigation of the direct association between fruit and vegetable intakes and insulin resistance in a carefully controlled intervention study is warranted. This study will investigate the dose-response effect of fruit and vegetable intake on insulin resistance in people who are overweight and at high-risk of CVD using state-of-the-art techniques.

Being tested
Fruit and vegetable intervention
Keywords
Fruit, Vegetables, Intervention, Insulin resistance, Cardiovascular disease risk, Dose response, High risk of cardiovascular disease
Medical subject headings
Cardiovascular Diseases, Insulin Resistance

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fruit and vegetable interventionOther

    Dose-response effect of fruit and vegetable intake (1-2 vs 4 vs 7 portions per day for 12 weeks)

Study groups in NCT00874341
Study groupRoleWhat they receive
1No interventionNot described
2Active comparator4 portions fruit and vegetables daily for 12 weeks
Receives: Other: Fruit and vegetable intervention
3Active comparator7 portions of fruit and vegetables daily for 12 weeks
Receives: Other: Fruit and vegetable intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Insulin resistance (two-step euglycaemic-hyperinsulinaemic clamp)

    Measured: Start and end of 12 week intervention

Secondary outcomes (3)
  1. Self-reported intake of fruit and vegetables (number of portions per day)

    Measured: Start and end of 12 week intervention

  2. Cardiovascular risk factors

    Measured: Start and end of 12 week intervention

  3. Biochemical markers of nutritional status

    Measured: Start and end of 12 week intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Apr 2009 (estimated)
  2. Study startJan 2009
  3. Primary completionJul 2011
  4. Study completionJul 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
105 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00874341
Sponsor's protocol ID
FSA study N02042
Acronym
FIRST
Status last verified
May 2015
First submitted
1 Apr 2009
Last updated
8 May 2015
Results posted
No
Data monitoring committee
No

Publications

  • Wallace IR, McEvoy CT, Hunter SJ, Hamill LL, Ennis CN, Bell PM, Patterson CC, Woodside JV, Young IS, McKinley MC. Dose-response effect of fruit and vegetables on insulin resistance in people at high risk of cardiovascular disease: a randomized controlled trial. Diabetes Care. 2013 Dec;36(12):3888-96. doi: 10.2337/dc13-0718. Epub 2013 Oct 15.

    PubMed 24130354
  • Wallace IR, McKinley MC, McEvoy CT, Hamill LL, Ennis CN, McGinty A, Bell PM, Patterson CC, Woodside JV, Young IS, Hunter SJ. Serum 25-hydroxyvitamin D and insulin resistance in people at high risk of cardiovascular disease: a euglycaemic hyperinsulinaemic clamp study. Clin Endocrinol (Oxf). 2016 Sep;85(3):386-92. doi: 10.1111/cen.13100. Epub 2016 Jun 13.

    PubMed 27175553
  • McEvoy CT, Wallace IR, Hamill LL, Neville CE, Hunter SJ, Patterson CC, Woodside JV, Chakravarthy U, Young IS, McKinley MC. Increasing fruit and vegetable intake has no effect on retinal vessel caliber in adults at high risk of developing cardiovascular disease. Nutr Metab Cardiovasc Dis. 2016 Apr;26(4):318-25. doi: 10.1016/j.numecd.2015.10.010. Epub 2015 Nov 14.

    PubMed 27004617
  • McEvoy CT, Wallace IR, Hamill LL, Hunter SJ, Neville CE, Patterson CC, Woodside JV, Young IS, McKinley MC. Increasing Fruit and Vegetable Intake Has No Dose-Response Effect on Conventional Cardiovascular Risk Factors in Overweight Adults at High Risk of Developing Cardiovascular Disease. J Nutr. 2015 Jul;145(7):1464-71. doi: 10.3945/jn.115.213090. Epub 2015 May 13.

    PubMed 25972532

Questions about this trial

What is this clinical trial studying?

A Phase 1 study testing Fruit and vegetable intervention in people with Cardiovascular Disease, run by Queen's University, Belfast at 2 sites in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 May 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Insulin resistance (two-step euglycaemic-hyperinsulinaemic clamp) (time frame: Start and end of 12 week intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00874341, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 May 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in